0.05Open0.05Pre Close0 Volume100 Open Interest4.00Strike Price0.00Turnover110.95%IV36.08%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0554Delta0.0595Gamma123.60Leverage Ratio-0.0037Theta-0.0003Rho-6.85Eff Leverage0.0019Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet